Viewing Study NCT00276003


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-01-04 @ 10:13 AM
Study NCT ID: NCT00276003
Status: COMPLETED
Last Update Posted: 2010-01-07
First Post: 2006-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
Sponsor: University of New Mexico
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module